Long-term Protection Against the Hepatitis B Virus Detected Through an Early Response to a Booster Dose Injection
Indian Pediatr
;
2018 Jan; 55(1): 45-48
Article
| IMSEAR
| ID: sea-199082
ABSTRACT
To determine the duration of protection conferred by the hepatitis B (HB)vaccination and the necessity of a booster dose. Methods:
Immediately after the initial bloodsampling, 252 youths (aged 18.8-20.5 years, 52% females) with a history of neonatal HBvaccination with one dose of the HB vaccine received a booster. Serum concentrations ofantibodies against the HB surface antigen were assessed in samples collected before and10-14 days after the booster. Seroconversion from concentrations <10 to ?10 IU/L weredefined as a positive immune response.Results:
Of the 252 participants, 131 were sero-susceptible and 114 responded.Conclusions:
Nearly 90% of young people preserved theirlong-term protection; the results of this study do not support the use of an HB boostervaccination
Full text:
Available
Index:
IMSEAR (South-East Asia)
Journal:
Indian Pediatr
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS